• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

获取更新的实验室程序:行动呼吁。

Access to newer laboratory procedures: a call for action.

作者信息

Hale Y M, Desmond E P, Jost K C, Salfinger M

机构信息

Bureau of Laboratories, Florida Department of Health, Jacksonville, USA.

出版信息

Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S171-5.

PMID:11144549
Abstract

Healthy People 2010, an initiative from the federal government, calls for action from tuberculosis controllers and tuberculosis laboratories in the fight to eliminate tuberculosis. Many patients, such as immunocompromised patients and those infected with multidrug-resistant tuberculosis strains, pose a challenge for care and diagnosis. Fortunately, many changes have occurred in the last decade to facilitate more rapid and accurate testing to assist with the care of these patients. California, Florida, New York and Texas have almost 50% of the tuberculosis cases in the United States, and their public health laboratories utilize different approaches to meet the same goal of rapid and accurate testing of specimens. With the targets of Healthy People 2010 (e.g., to reduce the average time for a laboratory to confirm and report tuberculosis cases to 2 days for 75% of cases) already looming on the horizon, innovative methods for achieving these goals should be evaluated. Using these public health laboratories as models, rapid, gold-standard testing methods should be provided to all patients in the United States. Soon it will be the year 2010..., are you ready to swiftly move forward?

摘要

“健康人民2010”是一项联邦政府倡议,呼吁结核病防控人员和结核病实验室采取行动,以消除结核病。许多患者,如免疫功能低下患者和感染耐多药结核菌株的患者,给护理和诊断带来了挑战。幸运的是,在过去十年中发生了许多变化,以促进更快速、准确的检测,从而协助护理这些患者。加利福尼亚州、佛罗里达州、纽约州和得克萨斯州的结核病病例占美国的近50%,其公共卫生实验室采用不同方法来实现对标本进行快速、准确检测的相同目标。随着“健康人民2010”的目标(例如,将实验室确认和报告结核病病例的平均时间缩短至2天,使75%的病例达到这一标准)已近在眼前,应评估实现这些目标的创新方法。以这些公共卫生实验室为榜样,应为美国所有患者提供快速、金标准的检测方法。很快就到2010年了……,你准备好迅速前进了吗?

相似文献

1
Access to newer laboratory procedures: a call for action.获取更新的实验室程序:行动呼吁。
Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S171-5.
2
[Mycobacterial tests].[分枝杆菌检测]
Kekkaku. 2008 Jan;83(1):43-59.
3
New diagnostic tools for tuberculosis.结核病的新型诊断工具。
Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S182-8.
4
[The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].[通过能力验证小组对商业实验室进行结核分枝杆菌药敏试验的外部质量评估]
Kekkaku. 2005 Apr;80(4):349-58.
5
Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States.结核分枝杆菌高耐药菌株W型在美国的传播。
Clin Infect Dis. 1999 Jul;29(1):85-92; discussion 93-5. doi: 10.1086/520187.
6
[Present trends of drug-resistant tuberculosis and how to manage it by mycobacterial laboratories].[耐药结核病的当前趋势以及分枝杆菌实验室如何对其进行管理]
Rinsho Byori. 2002 Sep;50(9):847-52.
7
Standardisation of sensitivity tests.敏感性试验的标准化
Int J Tuberc Lung Dis. 1998 Jan;2(1):69-70.
8
[Improvement of routine works and quality control in mycobacterial laboratory].[分枝杆菌实验室日常工作及质量控制的改进]
Kekkaku. 2007 Mar;82(3):217-27.
9
Laboratory practices for diagnosis of tuberculosis--United States, 1994.美国1994年结核病诊断实验室操作规范
MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):587-90.
10
[Anti-tuberculosis drug resistance survey in Japan, 2002: external quality assessment of results].[2002年日本抗结核药物耐药性调查:结果的外部质量评估]
Kekkaku. 2007 Mar;82(3):155-64.

引用本文的文献

1
Practical Guidance for Clinical Microbiology Laboratories: Mycobacteria.临床微生物学实验室实用指南:分枝杆菌。
Clin Microbiol Rev. 2018 Jan 31;31(2). doi: 10.1128/CMR.00038-17. Print 2018 Apr.
2
Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.使用涂片阳性样本评估基于聚合酶链反应的基因型MTBDR检测方法,以快速、直接地检测结核分枝杆菌复合群及其对异烟肼和利福平的耐药性。
J Clin Microbiol. 2006 Dec;44(12):4459-63. doi: 10.1128/JCM.01506-06. Epub 2006 Oct 11.
3
Does the MGIT 960 system improve the turnaround times for growth detection and susceptibility testing of the Mycobacterium tuberculosis complex?
MGIT 960系统能否缩短结核分枝杆菌复合群生长检测及药敏试验的周转时间?
J Clin Microbiol. 2006 Jun;44(6):2314-5. doi: 10.1128/JCM.00712-06.
4
Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.在耐多药结核病高发地区,将INNO-LiPA Rif.TB线性探针检测法直接应用于360份涂片阳性呼吸道标本,以快速鉴定结核分枝杆菌复合群菌株并检测利福平耐药性。
J Clin Microbiol. 2005 Sep;43(9):4880-4. doi: 10.1128/JCM.43.9.4880-4884.2005.
5
Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system.使用分子方法鉴定结核分枝杆菌复合群(MTBC)及其他分枝杆菌菌种,并在用BACTEC MGIT 960系统检测到MTBC分离株生长后检测其对利福平的耐药性。
J Clin Microbiol. 2003 Jul;41(7):2822-6. doi: 10.1128/JCM.41.7.2822-2826.2003.
6
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.结核分枝杆菌对异烟肼、利福平及吡嗪酰胺耐药性的分子基础
Respir Res. 2001;2(3):164-8. doi: 10.1186/rr54. Epub 2001 Apr 5.